Risk for excessive anticoagulation during hemodialysis is associated with type of vascular access and bedside coagulation testing: results of a cross-sectional study

HIGHLIGHTS

SUMMARY

Of biological monitoring of the unfractionated heparin effect have contributed to a pragmatic stance concerning dose adjustments. This study was conducted to assess the variability in UFH dosing and its clinical and biological anticoagulatory effects during hemodialysis in a prevalent cohort, and to identify explanatory factors of heparin dosing. Upon the start of chronic hemodialysis, UFH is administered according to a standing order using a loading dose of 2,500 IU UFH and a maintenance dose of 1,400 IU UFH/hour until completion of the hemodialysis session in case of catheter use and . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.